AEON Biopharma Discloses Going Concern Qualification

AEON Biopharma announced its Annual Shareholder Meeting will be held on June 17, 2026, at 10:00 am PT. The company also disclosed that its audited consolidated financial statements for the fiscal year ended December 31, 2025, included a going concern qualification from its independent registered public accounting firm. This qualification reflects the company's liquidity position, with cash and cash equivalents expected to fund operations into the third quarter of 2026.